These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 36380356)
1. Sarcoma classification by DNA methylation profiling in clinical everyday life: the Charité experience. Roohani S; Ehret F; Perez E; Capper D; Jarosch A; Flörcken A; Märdian S; Zips D; Kaul D Clin Epigenetics; 2022 Nov; 14(1):149. PubMed ID: 36380356 [TBL] [Abstract][Full Text] [Related]
2. DNA methylation-based profiling of bone and soft tissue tumours: a validation study of the 'DKFZ Sarcoma Classifier'. Lyskjaer I; De Noon S; Tirabosco R; Rocha AM; Lindsay D; Amary F; Ye H; Schrimpf D; Stichel D; Sill M; Koelsche C; Pillay N; Von Deimling A; Beck S; Flanagan AM J Pathol Clin Res; 2021 Jul; 7(4):350-360. PubMed ID: 33949149 [TBL] [Abstract][Full Text] [Related]
3. Can DNA Methylation Profiling Classify Histologic Subtypes and Grades in Soft Tissue Sarcoma? Kim H; Joo MW; Yoon J; Park HS; Kim JH; Lee JH; Kim SH; Lee SK; Chung YG; Cho YJ Clin Orthop Relat Res; 2024 Mar; 482(6):1028-37. PubMed ID: 38517415 [TBL] [Abstract][Full Text] [Related]
4. Sarcoma classification by DNA methylation profiling. Koelsche C; Schrimpf D; Stichel D; Sill M; Sahm F; Reuss DE; Blattner M; Worst B; Heilig CE; Beck K; Horak P; Kreutzfeldt S; Paff E; Stark S; Johann P; Selt F; Ecker J; Sturm D; Pajtler KW; Reinhardt A; Wefers AK; Sievers P; Ebrahimi A; Suwala A; Fernández-Klett F; Casalini B; Korshunov A; Hovestadt V; Kommoss FKF; Kriegsmann M; Schick M; Bewerunge-Hudler M; Milde T; Witt O; Kulozik AE; Kool M; Romero-Pérez L; Grünewald TGP; Kirchner T; Wick W; Platten M; Unterberg A; Uhl M; Abdollahi A; Debus J; Lehner B; Thomas C; Hasselblatt M; Paulus W; Hartmann C; Staszewski O; Prinz M; Hench J; Frank S; Versleijen-Jonkers YMH; Weidema ME; Mentzel T; Griewank K; de Álava E; Martín JD; Gastearena MAI; Chang KT; Low SYY; Cuevas-Bourdier A; Mittelbronn M; Mynarek M; Rutkowski S; Schüller U; Mautner VF; Schittenhelm J; Serrano J; Snuderl M; Büttner R; Klingebiel T; Buslei R; Gessler M; Wesseling P; Dinjens WNM; Brandner S; Jaunmuktane Z; Lyskjær I; Schirmacher P; Stenzinger A; Brors B; Glimm H; Heining C; Tirado OM; Sáinz-Jaspeado M; Mora J; Alonso J; Del Muro XG; Moran S; Esteller M; Benhamida JK; Ladanyi M; Wardelmann E; Antonescu C; Flanagan A; Dirksen U; Hohenberger P; Baumhoer D; Hartmann W; Vokuhl C; Flucke U; Petersen I; Mechtersheimer G; Capper D; Jones DTW; Fröhling S; Pfister SM; von Deimling A Nat Commun; 2021 Jan; 12(1):498. PubMed ID: 33479225 [TBL] [Abstract][Full Text] [Related]
5. Assessment of The Utility of The Sarcoma DNA Methylation Classifier In Surgical Pathology. Miettinen M; Abdullaev Z; Turakulov R; Quezado M; Luiña Contreras A; Curcio CA; Rys J; Chlopek M; Lasota J; Aldape KD Am J Surg Pathol; 2024 Jan; 48(1):112-122. PubMed ID: 37921028 [TBL] [Abstract][Full Text] [Related]
6. The central nervous system tumor methylation classifier changes neuro-oncology practice for challenging brain tumor diagnoses and directly impacts patient care. Karimi S; Zuccato JA; Mamatjan Y; Mansouri S; Suppiah S; Nassiri F; Diamandis P; Munoz DG; Aldape KD; Zadeh G Clin Epigenetics; 2019 Dec; 11(1):185. PubMed ID: 31806041 [TBL] [Abstract][Full Text] [Related]
7. DNA Methylation Profiling for Diagnosing Undifferentiated Sarcoma with Capicua Transcriptional Receptor ( Miele E; De Vito R; Ciolfi A; Pedace L; Russo I; De Pasquale MD; Di Giannatale A; Crocoli A; Angelis B; Tartaglia M; Alaggio R; Milano GM Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32155762 [TBL] [Abstract][Full Text] [Related]
8. DNA methylation profiling distinguishes Ewing-like sarcoma with EWSR1-NFATc2 fusion from Ewing sarcoma. Koelsche C; Kriegsmann M; Kommoss FKF; Stichel D; Kriegsmann K; Vokuhl C; Grünewald TGP; Romero-Pérez L; Kirchner T; de Alava E; Diaz-Martin J; Hartmann W; Baumhoer D; Antonescu CR; Szuhai K; Flucke U; Dirksen U; Pfister SM; Jones DTW; Mechtersheimer G; von Deimling A J Cancer Res Clin Oncol; 2019 May; 145(5):1273-1281. PubMed ID: 30895378 [TBL] [Abstract][Full Text] [Related]
9. Current updates in sarcoma biomarker discovery: emphasis on next-generation sequencing-based methods. Patton A; Dermawan JK Pathology; 2024 Mar; 56(2):274-282. PubMed ID: 38185613 [TBL] [Abstract][Full Text] [Related]
10. Methylation classifiers: Brain tumors, sarcomas, and what's next. Koelsche C; von Deimling A Genes Chromosomes Cancer; 2022 Jun; 61(6):346-355. PubMed ID: 35388566 [TBL] [Abstract][Full Text] [Related]
11. Pulmonary inflammatory leiomyosarcoma represents a potential diagnostic pitfall of DNA methylation-based classification of sarcomas: a case report. Shibayama T; Satomi K; Tanaka R; Yoshida A; Nagahama K; Hayashi A; Hibiya T; Suda K; Fujiwara M; Shibahara J BMC Pulm Med; 2023 Sep; 23(1):324. PubMed ID: 37667209 [TBL] [Abstract][Full Text] [Related]
13. Profiling of potential driver mutations in sarcomas by targeted next generation sequencing. Andersson C; Fagman H; Hansson M; Enlund F Cancer Genet; 2016 Apr; 209(4):154-60. PubMed ID: 26987750 [TBL] [Abstract][Full Text] [Related]
14. Primary intracranial spindle cell sarcoma with rhabdomyosarcoma-like features share a highly distinct methylation profile and DICER1 mutations. Koelsche C; Mynarek M; Schrimpf D; Bertero L; Serrano J; Sahm F; Reuss DE; Hou Y; Baumhoer D; Vokuhl C; Flucke U; Petersen I; Brück W; Rutkowski S; Zambrano SC; Garcia Leon JL; Diaz Coronado RY; Gessler M; Tirado OM; Mora J; Alonso J; Garcia Del Muro X; Esteller M; Sturm D; Ecker J; Milde T; Pfister SM; Korshunov A; Snuderl M; Mechtersheimer G; Schüller U; Jones DTW; von Deimling A Acta Neuropathol; 2018 Aug; 136(2):327-337. PubMed ID: 29881993 [TBL] [Abstract][Full Text] [Related]
15. Validation of Whole Genome Methylation Profiling Classifier for Central Nervous System Tumors. Santana-Santos L; Kam KL; Dittmann D; De Vito S; McCord M; Jamshidi P; Fowler H; Wang X; Aalsburg AM; Brat DJ; Horbinski C; Jennings LJ J Mol Diagn; 2022 Aug; 24(8):924-934. PubMed ID: 35605901 [TBL] [Abstract][Full Text] [Related]
16. Impact of the methylation classifier and ancillary methods on CNS tumor diagnostics. Wu Z; Abdullaev Z; Pratt D; Chung HJ; Skarshaug S; Zgonc V; Perry C; Pack S; Saidkhodjaeva L; Nagaraj S; Tyagi M; Gangalapudi V; Valdez K; Turakulov R; Xi L; Raffeld M; Papanicolau-Sengos A; O'Donnell K; Newford M; Gilbert MR; Sahm F; Suwala AK; von Deimling A; Mamatjan Y; Karimi S; Nassiri F; Zadeh G; Ruppin E; Quezado M; Aldape K Neuro Oncol; 2022 Apr; 24(4):571-581. PubMed ID: 34555175 [TBL] [Abstract][Full Text] [Related]
17. Role of Next-Generation Sequencing as a Diagnostic Tool for the Evaluation of Bone and Soft-Tissue Tumors. Szurian K; Kashofer K; Liegl-Atzwanger B Pathobiology; 2017; 84(6):323-338. PubMed ID: 28817827 [TBL] [Abstract][Full Text] [Related]
18. The Role of Next-Generation Sequencing in Sarcomas: Evolution From Light Microscope to Molecular Microscope. Groisberg R; Roszik J; Conley A; Patel SR; Subbiah V Curr Oncol Rep; 2017 Oct; 19(12):78. PubMed ID: 29030741 [TBL] [Abstract][Full Text] [Related]
19. Advances in sarcoma molecular diagnostics. Wang XQ; Goytain A; Dickson BC; Nielsen TO Genes Chromosomes Cancer; 2022 Jun; 61(6):332-345. PubMed ID: 35064596 [TBL] [Abstract][Full Text] [Related]
20. Fluorescence in Situ Hybridization (FISH) for Differential Diagnosis of Soft Tissue Sarcomas. Asif A; Mushtaq S; Hassan U; Akhtar N; Hussain M; Azam M; Qazi R Asian Pac J Cancer Prev; 2018 Mar; 19(3):655-660. PubMed ID: 29580035 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]